Monday, August 5, 2013

Why US senators want tougher sanctions on Iran's new president

In the US, 76 senators are demanding tougher economic sanctions to force Iran to scale back its nuclear program. President Obama wants to give Iran's President Hasan Rouhani time to act before any new sanctions.

By Bradley Klapper,?Associated Press / August 3, 2013

Coming and going: Iran's Supreme Leader Ayatollah Ali Khamenei, center, President-elect Hasan Rouhani, right, and outgoing President Mahmoud Ahmadinejad, sit, in an official endorsement ceremony for Rouhani, in Tehran, Iran, Saturday, Aug. 3, 2013.

(AP Photo/Office of the Iranian Supreme Leader)

Enlarge

As Iran's new president takes over, new U.S. penalties against the country appear a done deal.

Skip to next paragraph

' + google_ads[0].line2 + '
' + google_ads[0].line3 + '

'; } else if (google_ads.length > 1) { ad_unit += ''; } } document.getElementById("ad_unit").innerHTML += ad_unit; google_adnum += google_ads.length; return; } var google_adnum = 0; google_ad_client = "pub-6743622525202572"; google_ad_output = 'js'; google_max_num_ads = '1'; google_feedback = "on"; google_ad_type = "text"; // google_adtest = "on"; google_image_size = '230x105'; google_skip = '0'; // -->

In a letter to President Barack Obama, 76 senators are demanding tougher punishment on Iran's economy until the Islamic republic scales back its nuclear program. It also urges Obama to consider military options while keeping the door open to diplomacy.

The Senate letter, a copy of which was obtained Saturday by The Associated Press, comes just days after the House overwhelmingly passed new restrictions on Iran's oil sector and its mining and construction industries. Senators are expected to take up the same package in September.

"Until we see a significant slowdown of Iran's nuclear activities, we believe our nation must toughen sanctions and reinforce the credibility of our option to use military force at the same time as we fully explore a diplomatic solution to our dispute with Iran," says the letter, which will be delivered Monday.

The Obama administration is concerned Congress' effort could undercut Iran's relatively moderate President-elect Hasan Rouhani, who was formally endorsed by Iran's ayatollah on Saturday and takes the oath of office Sunday. Rouhani has pledged to follow a "path of moderation" and promised greater openness over Iran's nuclear program.

Obama wants to give Rouhani a chance to prove his seriousness.

The U.S. believes Iran has been working for years to develop nuclear weapons. Iran insists its program is for peaceful energy and research purposes.

Rouhani's victory signaled Iran's clear dissatisfaction, the senators said. But they noted that all final decisions on nuclear matters rest with Supreme Leader Ayatollah Ali Khamenei and said Iran must not be allowed to use any new nuclear negotiations with world powers to stall for time.

"Iran today continues its large-scale installation of advanced centrifuges," their letter said. "This will soon put it in the position to be able to rapidly produce weapons-grade uranium, bringing Tehran to the brink of a nuclear weapons capability."

"We need to understand quickly whether Tehran is at last ready to negotiate seriously," it added. "Iran needs to understand that the time for diplomacy is nearing its end."

Obama prefers diplomacy. He has given Iran until sometime next spring to prove to the world that its program is peaceful.

If Iran fails to do so, the stage may be set for military intervention from the U.S. or Israel, which sees Iranian nuclear weapons capacity as an existential threat and has warned of taking action according to its own timeline.

Copyright 2013 The Associated Press.

Source: http://rss.csmonitor.com/~r/feeds/csm/~3/Ta6COy1FAY0/Why-US-senators-want-tougher-sanctions-on-Iran-s-new-president

southern university biggest loser TJ Lane lindsey vonn lindsey vonn nit first day of spring

Sunday, August 4, 2013

Mental health in the US: New ideas on care emerge

Mass shootings by mentally unstable people have focused attention on the inadequacies of the US mental health care system, in which less than half of the seriously ill can get treatment.?

By Amanda Paulson,?Staff writer / August 4, 2013

A room at a Parachute NYC respite care facility is seen in this photo. This is the cover story in the Aug. 5 issue of The Christian Science MonitorWeekly.

Ann Hermes/The Christian Science Monitor

Enlarge

Patti Sacher's daughter, Lisa, was 19 when she first started to show signs of mental illness.

Skip to next paragraph

' + google_ads[0].line2 + '
' + google_ads[0].line3 + '

'; } else if (google_ads.length > 1) { ad_unit += ''; } } document.getElementById("ad_unit").innerHTML += ad_unit; google_adnum += google_ads.length; return; } var google_adnum = 0; google_ad_client = "pub-6743622525202572"; google_ad_output = 'js'; google_max_num_ads = '1'; google_feedback = "on"; google_ad_type = "text"; // google_adtest = "on"; google_image_size = '230x105'; google_skip = '0'; // -->

"It was like getting hit from behind by a Mack truck," says Ms. Sacher, when Lisa, a bubbly, lighthearted college sophomore living in Madison, Wis., started to talk about hearing voices, showing signs of paranoia, and using drugs. Police, on one occasion, even had to drag her out of the middle of a busy street where she stood screaming at tormenters seen only by her.

When Lisa dropped out of school, Sacher and her husband acted on their feelings of love and responsibility for their daughter and tried to bring her home for treatment. But Lisa resisted, and they found out they had no authority to compel the school or anyone else to help: Lisa was no longer a minor. That helpless realization was just the beginning of a 17-year effort to help her.

Though they did eventually bring her home, Lisa (a pseudonym her mother uses) refused most treatment for her diagnosis of schizophrenia and would stop taking the medication prescribed for her because she didn't like the side effects and didn't think she needed it. She went to three residential treatment programs, but ran away each time. Her mother managed at least half a dozen times to get Lisa hospitalized, but the short stints did little good ? she inevitably ended up endangering herself.

"I used to think it was only bad parents who had kids who ended up like that," says Sacher, who now volunteers for the New York City chapter of the National Alliance on Mental Illness, teaching a "family-to-family" class for those struggling with the same issues she has.

Sacher remembers being struck by an article in a newspaper asking people to help look for a missing elderly man with Alzheimer's disease: Some mental illnesses arouse sympathy and others blame, she says.

Sacher's frustrations with the mental health care system in this country are typical. It's a system nearly everyone agrees is fragmented, inadequate, and offers little help until someone reaches a crisis ? and often not even then.

Now, after a succession of shooting massacres ? by Adam Lanza in Newtown, Conn.; Jared Loughner in Tucson, Ariz.; James Holmes in Aurora, Colo.; and John Zawahri in Santa Monica, Calif. ? the mental health care system is in the limelight to a degree it hasn't been in decades. In the case of Mr. Lanza, who killed 27 people, including 20 first-graders and his mother, before killing himself, there isn't much conclusive known about his mental-health history ? and what information there is doesn't explain what might have caused him to commit such violence. It is clear he was troubled, and the shooting sparked a massive outcry over the need for better treatment for the mentally ill.

President Obama called for a national conversation on mental health and sponsored a one-day conference on the issue in June, calling for more help for young people and veterans, in particular, and saying it's time to "[bring] mental illness out of the shadows."

1?|?2?|?3?|?4?|?5?|?6?|?7

Source: http://rss.csmonitor.com/~r/feeds/csm/~3/JgGKDpRp7BM/Mental-health-in-the-US-New-ideas-on-care-emerge

black friday How long to cook a turkey green bean casserole green bean casserole recipe red dawn sweet potato pie sweet potato pie

Most Irreplaceable Cincinnati Bengals Player for the 2013 NFL Season

Jake Roth-USA TODAY Sports

?

The Cincinnati Bengals?have made the playoffs for two consecutive seasons, but each time the Houston Texans have dismissed them in the Wild Card Round. 2013 brings hope of continuing that postseason streak, and the Bengals are widely regarded as?a team on the rise.

The Bengals found their quarterback of the future in the second round of the 2011 NFL Draft, and Andy Dalton?has started every game in his first two seasons. But when thinking about who is the most irreplaceable player on Cincinnati?s roster, another player who is entering his third season jumps to the head of the class.

Wide receiver A.J. Green has immediately become one of the top young stars in the NFL, catching a total of 162 passes for over 2,400 yards and 18 touchdowns over the last two seasons. He finished in the top 10 of the league in receptions (97-seventh), receiving yards (1,350-10th) and touchdowns (11-tied for fourth) last season, along with a streak of nine straight games with a touchdown (10 total), and if not for a slow finish (less than 60 receiving yards in three of the final four games) his numbers would have been even better.

The Bengals had no one else besides Green with more than 64 receptions, 737 yards?and five touchdowns last season (tight end Jermaine Gresham in all three cases) and other than Andrew Hawkins (51 receptions) no other wide receiver had more than 20 catches. Injuries to Mohamed Sanu and Marvin Jones depleted an already thin receiving corp at different points in the season,?which served to make Dalton even more reliant on Green.

Cincinnati did add some talent in April?s draft by using early picks on tight end Tyler Eifert and running back Giovani Bernard, but Green is still sure to be Dalton?s top target and a driving force for the team?s entire offense again this season.

Brad Berreman is a contributing writer at Rant Sports.com. Follow him on Twitter @bradberreman24.

Source: http://www.rantsports.com/nfl/2013/08/04/most-irreplaceable-cincinnati-bengals-player-for-the-2013-nfl-season/

dalai lama tamera mowry slow jam the news madden cover obama slow jams the news ron artest gladys knight

BioTech News Headlines - Yahoo! News

BioTech News Headlines - Yahoo! Newshttp://news.yahoo.com/biotech/ Get the latest Biotech news headlines from Yahoo! News. Find breaking Biotech news, including analysis and opinion on top Biotech stories, photos and more.en-USCopyright (c) 2013 Yahoo! Inc. All rights reservedThu, 01 Aug 2013 15:45:37 -04005BioTech News Headlines - Yahoo! Newshttp://news.yahoo.com/biotech/ http://l.yimg.com/a/i/us/nws/th/main_142c.gifAffymetrix shares climb after 2Q tops St. viewShares of Affymetrix Inc. climbed Thursday, a day after the genetic testing instrument maker turned in a second-quarter performance that topped Wall Street expectations. THE SPARK: The Santa Clara, Calif., ...http://news.yahoo.com/affymetrix-shares-climb-2q-tops-194537613.htmlThu, 01 Aug 2013 15:45:37 -0400Associated Pressaffymetrix-shares-climb-2q-tops-194537613Top French court backs stem-cell research<p><a href="http://news.yahoo.com/top-french-court-backs-stem-cell-research-173058916.html"><img src="http://l1.yimg.com/bt/api/res/1.2/2X9ACReIjdgPrbygDFhxZg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-08-01T173058Z_1_CBRE9701CNQ00_RTROPTP_2_FRANCE.JPG" width="130" height="86" alt="A researcher works in his laboratory at the Institute for Stem cell Therapy and Exploration of Monogenic Diseases (I-Stem) in Evry, near Paris" align="left" title="A researcher works in his laboratory at the Institute for Stem cell Therapy and Exploration of Monogenic Diseases (I-Stem) in Evry, near Paris" border="0" /></a>PARIS (Reuters) - France&#039;s top court approved a law on Thursday making it easier to conduct research on human embryos and stem cells as long as strict rules are followed to prevent cloning. Predominantly Roman Catholic France has until now had tough curbs on embryonic stem cell research under a 2011 law that only allows it with the explicit approval from the national biomedicine agency. ...</p><br clear="all"/>http://news.yahoo.com/top-french-court-backs-stem-cell-research-173058916.htmlThu, 01 Aug 2013 13:30:58 -0400Reuterstop-french-court-backs-stem-cell-research-173058916<p><a href="http://news.yahoo.com/top-french-court-backs-stem-cell-research-173058916.html"><img src="http://l1.yimg.com/bt/api/res/1.2/2X9ACReIjdgPrbygDFhxZg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-08-01T173058Z_1_CBRE9701CNQ00_RTROPTP_2_FRANCE.JPG" width="130" height="86" alt="A researcher works in his laboratory at the Institute for Stem cell Therapy and Exploration of Monogenic Diseases (I-Stem) in Evry, near Paris" align="left" title="A researcher works in his laboratory at the Institute for Stem cell Therapy and Exploration of Monogenic Diseases (I-Stem) in Evry, near Paris" border="0" /></a>PARIS (Reuters) - France&#039;s top court approved a law on Thursday making it easier to conduct research on human embryos and stem cells as long as strict rules are followed to prevent cloning. Predominantly Roman Catholic France has until now had tough curbs on embryonic stem cell research under a 2011 law that only allows it with the explicit approval from the national biomedicine agency. ...</p><br clear="all"/>Affymetrix takes 2Q loss, but shares trade higherGenetic testing instrument maker Affymetrix Inc. said Wednesday it took a loss in the second quarter, but its shares advanced in aftermarket trading. Affymetrix said its revenue rose 20 percent, thanks ...http://news.yahoo.com/affymetrix-takes-2q-loss-shares-213120760.htmlWed, 31 Jul 2013 17:31:20 -0400Associated Pressaffymetrix-takes-2q-loss-shares-213120760Crop biotech company to expand by 150 jobs by 2018A global agriculture biotechnology company is expanding its North Carolina operations with plans to add 150 new jobs within about five years. Syngenta Biotechnology Inc. said Tuesday it will expand its ...http://news.yahoo.com/crop-biotech-company-expand-150-173241540.htmlTue, 30 Jul 2013 13:32:41 -0400Associated Presscrop-biotech-company-expand-150-173241540Single Genetic Glitch May Explain Most Allergies and AsthmaAllergies are certainly the result of both genetic and environmental factors, but there is fresh evidence to suggest that at least one major genetic aberration could be behind everything from hay fever to food allergies to asthma.http://news.yahoo.com/single-genetic-glitch-may-explain-most-allergies-asthma-150047701.htmlThu, 25 Jul 2013 11:00:47 -0400Time.comsingle-genetic-glitch-may-explain-most-allergies-asthma-150047701Thermo Fisher second-quarter profit narrowly beats estimates(Reuters) - Thermo Fisher Scientific Inc reported a second-quarter profit that was slightly ahead of analysts' expectation, and said it was making progress in planning for its $13.6 billion acquisition of genetic testing company Life Technologies Inc . Thermo Fisher, the world's largest maker of laboratory equipment and scientific instruments, said its net profit rose to $277.4 million, or 76 cents per share, in the quarter ended June 29 from $233.8 million, or 63 cents per share, a year ago. Excluding special items, Thermo Fisher earned $1.32 per share. Analysts on average expected $1. ...http://news.yahoo.com/thermo-fisher-second-quarter-profit-narrowly-beats-estimates-100724726.htmlWed, 24 Jul 2013 06:07:24 -0400Reutersthermo-fisher-second-quarter-profit-narrowly-beats-estimates-100724726Illumina says 2Q net income spikes, lifts outlookIllumina Inc., which makes genetic testing tools, said Tuesday that its net income climbed 53 percent in the second quarter as it booked fewer charges and posted a big jump in product and service revenue. ...http://news.yahoo.com/illumina-says-2q-net-income-230632889.htmlTue, 23 Jul 2013 19:06:32 -0400Associated Pressillumina-says-2q-net-income-230632889New Genes IDd in Obesity: How Much of Weight is Genetic?Two studies zero in on DNA-based drivers of weight. Is obesity written in our genes?http://news.yahoo.com/news-genes-idd-obesity-much-weight-genetic-094549684.htmlFri, 19 Jul 2013 05:45:49 -0400Time.comnews-genes-idd-obesity-much-weight-genetic-094549684Largest cancer gene database made publicBy Deena Beasley (Reuters) - National Cancer Institute scientists have released the largest-ever database of cancer-related genetic variations, providing researchers the most comprehensive way so far to figure out how to target treatments for the disease. Open access worldwide to the new database, based on genome studies, is expected to help researchers accelerate development of new drugs and better match patients with therapies, NCI said in a statement on Monday. "Most anti-cancer drugs that are used today are used based on their empirical activity," Dr. ...http://news.yahoo.com/largest-cancer-gene-database-made-public-232153763.htmlMon, 15 Jul 2013 19:21:53 -0400Reuterslargest-cancer-gene-database-made-public-232153763Scientists find how 'obesity gene' makes people fat<p><a href="http://news.yahoo.com/scientists-obesity-gene-makes-people-fat-160050035.html"><img src="http://l.yimg.com/bt/api/res/1.2/jeVsgLvIwwPLuyxd8rMoOg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-15T184811Z_1_CBRE96E1G8E00_RTROPTP_2_BRITAIN.JPG" width="130" height="86" alt="A man sits on a bench in central London" align="left" title="A man sits on a bench in central London" border="0" /></a>By Ben Hirschler LONDON (Reuters) - Scientists have unraveled how a gene long associated with obesity makes people fat by triggering increased hunger, opening up potential new ways to fight a growing global health problem. A common variation in the FTO gene affects one in six of the population, making them 70 percent more likely to become obese - but until now experts did not know why. ...</p><br clear="all"/>http://news.yahoo.com/scientists-obesity-gene-makes-people-fat-160050035.htmlMon, 15 Jul 2013 14:49:20 -0400Reutersscientists-obesity-gene-makes-people-fat-160050035<p><a href="http://news.yahoo.com/scientists-obesity-gene-makes-people-fat-160050035.html"><img src="http://l.yimg.com/bt/api/res/1.2/jeVsgLvIwwPLuyxd8rMoOg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-15T184811Z_1_CBRE96E1G8E00_RTROPTP_2_BRITAIN.JPG" width="130" height="86" alt="A man sits on a bench in central London" align="left" title="A man sits on a bench in central London" border="0" /></a>By Ben Hirschler LONDON (Reuters) - Scientists have unraveled how a gene long associated with obesity makes people fat by triggering increased hunger, opening up potential new ways to fight a growing global health problem. A common variation in the FTO gene affects one in six of the population, making them 70 percent more likely to become obese - but until now experts did not know why. ...</p><br clear="all"/>Alnylam bets on 'gene silencing' to woo biotech investorsBy Esha Dey and Pallavi Ail (Reuters) - A radical new treatment for genetic disorders has catapulted Alnylam Pharmaceuticals Inc into the crosshairs of investors seeking the next breakthrough name in biotechnology. The challenge for the Cambridge, Massachusetts-based company now is to prove that its 'gene silencing' technology can make the leap from the laboratory to the doctor's office and eclipse an alternative therapy already in use. Investors, for now, are betting that it will. A steady drip of positive trial data has helped to triple Alnylam's market value to more than $2. ...http://news.yahoo.com/alnylam-bets-gene-silencing-woo-biotech-investors-144723013.htmlFri, 12 Jul 2013 10:47:23 -0400Reutersalnylam-bets-gene-silencing-woo-biotech-investors-144723013Alnylam drug found effective in treating rare genetic disease(Reuters) - Alnylam Pharmaceuticals Inc said an early-stage trial of its gene-based therapy showed the drug was effective in suppressing a protein that causes a rare organ-damaging hereditary disorder. Alnylam shares rose 14 percent to $42.80 in premarket trade. The study was testing a subcutaneously administered version of the drug, ALN-TTR, to treat genetic disorder amyloidosis, which is caused by deposits of protein in tissues and organs. ...http://news.yahoo.com/alnylam-drug-found-effective-treating-rare-genetic-disease-132403151.htmlThu, 11 Jul 2013 09:24:03 -0400Reutersalnylam-drug-found-effective-treating-rare-genetic-disease-132403151Myriad sues competitor overs cancer gene testMyriad Genetics Inc. is suing two privately-held competitors to stop it from selling a genetic test that competes with Myriad's BRACAnalysis breast and ovarian cancer test. Myriad says Ambry Genetics Corp. ...http://news.yahoo.com/myriad-sues-competitor-overs-cancer-223108993.htmlWed, 10 Jul 2013 18:31:08 -0400Associated Pressmyriad-sues-competitor-overs-cancer-223108993Myriad sues competitor over cancer gene testMyriad Genetics Inc. is suing a privately-held competitor to stop it from selling a genetic test that competes with Myriad's BRACAnalysis breast and ovarian cancer test. Myriad says Ambry Genetics Corp. ...http://news.yahoo.com/myriad-sues-competitor-over-cancer-205137780.htmlWed, 10 Jul 2013 16:51:37 -0400Associated Pressmyriad-sues-competitor-over-cancer-205137780First child to receive windpipe grown from own stem cells dies<p><a href="http://news.yahoo.com/first-child-receive-windpipe-grown-own-stem-cells-160616412.html"><img src="http://l1.yimg.com/bt/api/res/1.2/GFPuq_Gz_TFcEb7GGPwOlg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-09T163904Z_1_CBRE9681A9700_RTROPTP_2_USA-ILLINOIS-STEMCELL.JPG" width="130" height="86" alt="Hannah Warren is pictured at the Children&#039;s Hospital of Illinois, in Peoria, Illinois" align="left" title="Hannah Warren is pictured at the Children&#039;s Hospital of Illinois, in Peoria, Illinois" border="0" /></a>By Chris Francescani (Reuters) - Two-year-old Hannah Warren, the first child to receive a windpipe grown from her own stem cells, has died three months after a rare operation, the Children&#039;s Hospital of Illinois in Peoria said. The child was diagnosed with an uncommon congenital abnormality known as tracheal agenesis, which means her windpipe failed to develop. She could not talk, eat or swallow on her own, according to a website by her parents, Darryl and Young-Mi Warren. ...</p><br clear="all"/>http://news.yahoo.com/first-child-receive-windpipe-grown-own-stem-cells-160616412.htmlTue, 09 Jul 2013 13:10:48 -0400Reutersfirst-child-receive-windpipe-grown-own-stem-cells-160616412<p><a href="http://news.yahoo.com/first-child-receive-windpipe-grown-own-stem-cells-160616412.html"><img src="http://l1.yimg.com/bt/api/res/1.2/GFPuq_Gz_TFcEb7GGPwOlg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-09T163904Z_1_CBRE9681A9700_RTROPTP_2_USA-ILLINOIS-STEMCELL.JPG" width="130" height="86" alt="Hannah Warren is pictured at the Children&#039;s Hospital of Illinois, in Peoria, Illinois" align="left" title="Hannah Warren is pictured at the Children&#039;s Hospital of Illinois, in Peoria, Illinois" border="0" /></a>By Chris Francescani (Reuters) - Two-year-old Hannah Warren, the first child to receive a windpipe grown from her own stem cells, has died three months after a rare operation, the Children&#039;s Hospital of Illinois in Peoria said. The child was diagnosed with an uncommon congenital abnormality known as tracheal agenesis, which means her windpipe failed to develop. She could not talk, eat or swallow on her own, according to a website by her parents, Darryl and Young-Mi Warren. ...</p><br clear="all"/>2 stem cell patients stop HIV drugs, no virus seen<p><a href="http://news.yahoo.com/2-stem-cell-patients-stop-hiv-drugs-no-112746486.html"><img src="http://l3.yimg.com/bt/api/res/1.2/d8LencqPZ80U5zMMq9YShw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/427a1fd937878116360f6a706700835f.jpg" width="130" height="86" alt="Timothy Henrich of the Harvard-affiliated Brigham and Women&#039;s Hospital in Boston speaks at the International AIDS Society Conference 2013 in Kuala Lumpur, Malaysia, Wednesday, July 3, 2013. Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday. (AP Photo/Lai Seng Sin)" align="left" title="Timothy Henrich of the Harvard-affiliated Brigham and Women&#039;s Hospital in Boston speaks at the International AIDS Society Conference 2013 in Kuala Lumpur, Malaysia, Wednesday, July 3, 2013. Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday. (AP Photo/Lai Seng Sin)" border="0" /></a>KUALA LUMPUR, Malaysia (AP) ? Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday.</p><br clear="all"/>http://news.yahoo.com/2-stem-cell-patients-stop-hiv-drugs-no-112746486.htmlWed, 03 Jul 2013 07:36:09 -0400Associated Press2-stem-cell-patients-stop-hiv-drugs-no-112746486<p><a href="http://news.yahoo.com/2-stem-cell-patients-stop-hiv-drugs-no-112746486.html"><img src="http://l3.yimg.com/bt/api/res/1.2/d8LencqPZ80U5zMMq9YShw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/427a1fd937878116360f6a706700835f.jpg" width="130" height="86" alt="Timothy Henrich of the Harvard-affiliated Brigham and Women&#039;s Hospital in Boston speaks at the International AIDS Society Conference 2013 in Kuala Lumpur, Malaysia, Wednesday, July 3, 2013. Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday. (AP Photo/Lai Seng Sin)" align="left" title="Timothy Henrich of the Harvard-affiliated Brigham and Women&#039;s Hospital in Boston speaks at the International AIDS Society Conference 2013 in Kuala Lumpur, Malaysia, Wednesday, July 3, 2013. Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday. (AP Photo/Lai Seng Sin)" border="0" /></a>KUALA LUMPUR, Malaysia (AP) ? Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday.</p><br clear="all"/>Scientists create human liver from stem cellsBy Kate Kelland LONDON (Reuters) - Scientists have for the first time created a functional human liver from stem cells derived from skin and blood and say their success points to a future where much-needed livers and other transplant organs could be made in a laboratory. While it may take another 10 years before lab-grown livers could be used to treat patients, the Japanese scientists say they now have important proof of concept that paves the way for more ambitious organ-growing experiments. ...http://news.yahoo.com/scientists-create-human-liver-stem-cells-033554646.htmlWed, 03 Jul 2013 23:35:54 -0400Reutersscientists-create-human-liver-stem-cells-033554646Stem-cell therapy wipes out HIV in two patientsBy Ben Hirschler LONDON (Reuters) - Two men with HIV have been off AIDS drugs for several months after receiving stem-cell transplants for cancer that appear to have cleared the virus from their bodies, researchers reported on Wednesday. Both patients, who were treated in Boston and had been on long-term drug therapy to control their HIV, received stem-cell transplants after developing lymphoma, a type of blood cancer. ...http://news.yahoo.com/stem-cell-therapy-wipes-hiv-two-patients-115302059.htmlWed, 03 Jul 2013 07:53:02 -0400Reutersstem-cell-therapy-wipes-hiv-two-patients-115302059World Food Prize goes to 3 biotech scientists<p><a href="http://news.yahoo.com/world-food-prize-goes-3-170632624.html"><img src="http://l1.yimg.com/bt/api/res/1.2/KhghTjhCNUmZ9Q_xzFkPtA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://globalfinance.zenfs.com/images/US_AHTTP_AP_FINANCIALTIMES/28f0b2d288923914350f6a706700cc56_original.jpg" width="130" height="86" alt="World Food Prize goes to 3 biotech scientists" align="left" title="World Food Prize goes to 3 biotech scientists" border="0" /></a>The World Food Prize Foundation on Wednesday took the bold step of awarding this year&#039;s prize to three pioneers of plant biotechnology whose work brought the world genetically modified crops. The private ...</p><br clear="all"/>http://news.yahoo.com/world-food-prize-goes-3-170632624.htmlWed, 19 Jun 2013 14:39:54 -0400Associated Pressworld-food-prize-goes-3-170632624<p><a href="http://news.yahoo.com/world-food-prize-goes-3-170632624.html"><img src="http://l1.yimg.com/bt/api/res/1.2/KhghTjhCNUmZ9Q_xzFkPtA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://globalfinance.zenfs.com/images/US_AHTTP_AP_FINANCIALTIMES/28f0b2d288923914350f6a706700cc56_original.jpg" width="130" height="86" alt="World Food Prize goes to 3 biotech scientists" align="left" title="World Food Prize goes to 3 biotech scientists" border="0" /></a>The World Food Prize Foundation on Wednesday took the bold step of awarding this year&#039;s prize to three pioneers of plant biotechnology whose work brought the world genetically modified crops. The private ...</p><br clear="all"/>Bluebird Bio shares rocket higher in trading debutNEW YORK (AP) ? Shares of gene therapy developer Bluebird Bio Inc. surged in their trading debut.http://news.yahoo.com/bluebird-bio-shares-rocket-higher-trading-debut-152519370.htmlWed, 19 Jun 2013 19:12:45 -0400Associated Pressbluebird-bio-shares-rocket-higher-trading-debut-152519370Court ruling may open up breast cancer gene tests<p><a href="http://news.yahoo.com/court-ruling-may-open-breast-cancer-gene-tests-180022078.html"><img src="http://l2.yimg.com/bt/api/res/1.2/94lCu8UF8oTJAV2lEoTwLQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/d1f04896cf25a913340f6a706700a121.jpg" width="130" height="86" alt="FILE - A technician loads patient samples into a machine for testing at Myriad Genetics Friday, May 31, 2002, in Salt Lake City. DNA samples are moved from one tray to another by the eight-needle apparatus at left. The Supreme Court ruled Thursday, June 13, 2013 that Myriad Genetics Inc. cannot patent the BRCA genes, which are tested to check a woman?s risk for breast and ovarian cancer. Mutations in these genes are what led Angelina Jolie to have both her breasts removed because she had such a high cancer risk. Some experts think the court ruling may lead to lower cost testing because there could be more competition. (AP Photo/Douglas C. Pizac)" align="left" title="FILE - A technician loads patient samples into a machine for testing at Myriad Genetics Friday, May 31, 2002, in Salt Lake City. DNA samples are moved from one tray to another by the eight-needle apparatus at left. The Supreme Court ruled Thursday, June 13, 2013 that Myriad Genetics Inc. cannot patent the BRCA genes, which are tested to check a woman?s risk for breast and ovarian cancer. Mutations in these genes are what led Angelina Jolie to have both her breasts removed because she had such a high cancer risk. Some experts think the court ruling may lead to lower cost testing because there could be more competition. (AP Photo/Douglas C. Pizac)" border="0" /></a>A ruling by the Supreme Court that human genes can&#039;t be patented is expected to increase access and drop the cost for tests for gene mutations that greatly raise the risk of developing breast or ovarian cancer.</p><br clear="all"/>http://news.yahoo.com/court-ruling-may-open-breast-cancer-gene-tests-180022078.htmlThu, 13 Jun 2013 19:35:35 -0400Associated Presscourt-ruling-may-open-breast-cancer-gene-tests-180022078<p><a href="http://news.yahoo.com/court-ruling-may-open-breast-cancer-gene-tests-180022078.html"><img src="http://l2.yimg.com/bt/api/res/1.2/94lCu8UF8oTJAV2lEoTwLQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/ap_webfeeds/d1f04896cf25a913340f6a706700a121.jpg" width="130" height="86" alt="FILE - A technician loads patient samples into a machine for testing at Myriad Genetics Friday, May 31, 2002, in Salt Lake City. DNA samples are moved from one tray to another by the eight-needle apparatus at left. The Supreme Court ruled Thursday, June 13, 2013 that Myriad Genetics Inc. cannot patent the BRCA genes, which are tested to check a woman?s risk for breast and ovarian cancer. Mutations in these genes are what led Angelina Jolie to have both her breasts removed because she had such a high cancer risk. Some experts think the court ruling may lead to lower cost testing because there could be more competition. (AP Photo/Douglas C. Pizac)" align="left" title="FILE - A technician loads patient samples into a machine for testing at Myriad Genetics Friday, May 31, 2002, in Salt Lake City. DNA samples are moved from one tray to another by the eight-needle apparatus at left. The Supreme Court ruled Thursday, June 13, 2013 that Myriad Genetics Inc. cannot patent the BRCA genes, which are tested to check a woman?s risk for breast and ovarian cancer. Mutations in these genes are what led Angelina Jolie to have both her breasts removed because she had such a high cancer risk. Some experts think the court ruling may lead to lower cost testing because there could be more competition. (AP Photo/Douglas C. Pizac)" border="0" /></a>A ruling by the Supreme Court that human genes can&#039;t be patented is expected to increase access and drop the cost for tests for gene mutations that greatly raise the risk of developing breast or ovarian cancer.</p><br clear="all"/>As top court invalidates some gene patents, biotech has moved onBy Sharon Begley NEW YORK (Reuters) - The U.S. Supreme Court decision on Thursday to uphold patent protections for genetic material that has been changed in the laboratory but invalidate patents for purely natural DNA may seem like a partial setback for the biotech industry, but experts said it isn't: the industry has already moved on. ...http://news.yahoo.com/top-court-invalidates-gene-patents-biotech-moved-230732022.htmlThu, 13 Jun 2013 19:07:32 -0400Reuterstop-court-invalidates-gene-patents-biotech-moved-230732022News Summary: Myriad stock volatile on gene rulingROLLERCOASTER REACTION: Diagnostic test maker Myriad Genetics saw its shares jump 10 percent, then plunge. The volatility was triggered by the Supreme Court's mixed ruling on the validity of patents for ...http://news.yahoo.com/news-summary-myriad-stock-volatile-224626640.htmlThu, 13 Jun 2013 18:46:26 -0400Associated Pressnews-summary-myriad-stock-volatile-224626640High court ruling on gene patents lifts MyriadShares of diagnostic test maker Myriad Genetics Inc. surged Thursday after the Supreme Court handed the company a partial victory in a battle over validity of Myriad patents underlying its lucrative test ...http://news.yahoo.com/high-court-ruling-gene-patents-155411757.htmlThu, 13 Jun 2013 15:08:11 -0400Associated Presshigh-court-ruling-gene-patents-155411757Analysis: Biotech wheat furor shows GM food safety debate far from settled<p><a href="http://news.yahoo.com/analysis-biotech-wheat-furor-shows-gm-food-safety-210446592.html"><img src="http://l3.yimg.com/bt/api/res/1.2/yc0IrkFnfD0n5h_2z4NwZg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-06-10T213442Z_1_CBRE9591NXY00_RTROPTP_2_US-WHEAT-KOREA.JPG" width="130" height="86" alt="An examiner demonstrates analyzing a genetically modified wheat sample, at the Ministry of Food and Drug Safety in Seoul" align="left" title="An examiner demonstrates analyzing a genetically modified wheat sample, at the Ministry of Food and Drug Safety in Seoul" border="0" /></a>By Carey Gillam (Reuters) - The refusal of some foreign buyers to purchase U.S. wheat after an unapproved genetically modified strain was discovered growing in a farm field in Oregon is the latest demonstration that the issue of biotech food safety is far from settled. Japan and South Korea canceled purchases of U.S. wheat after the discovery of the experimental wheat developed by Monsanto Co. The furor erupted just days after a May 25 protest in cities around the world targeting Monsanto, the leading developer of crops with transgenic DNA. At the crux of the concerns is the question of ...</p><br clear="all"/>http://news.yahoo.com/analysis-biotech-wheat-furor-shows-gm-food-safety-210446592.htmlMon, 10 Jun 2013 17:12:14 -0400Reutersanalysis-biotech-wheat-furor-shows-gm-food-safety-210446592<p><a href="http://news.yahoo.com/analysis-biotech-wheat-furor-shows-gm-food-safety-210446592.html"><img src="http://l3.yimg.com/bt/api/res/1.2/yc0IrkFnfD0n5h_2z4NwZg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-06-10T213442Z_1_CBRE9591NXY00_RTROPTP_2_US-WHEAT-KOREA.JPG" width="130" height="86" alt="An examiner demonstrates analyzing a genetically modified wheat sample, at the Ministry of Food and Drug Safety in Seoul" align="left" title="An examiner demonstrates analyzing a genetically modified wheat sample, at the Ministry of Food and Drug Safety in Seoul" border="0" /></a>By Carey Gillam (Reuters) - The refusal of some foreign buyers to purchase U.S. wheat after an unapproved genetically modified strain was discovered growing in a farm field in Oregon is the latest demonstration that the issue of biotech food safety is far from settled. Japan and South Korea canceled purchases of U.S. wheat after the discovery of the experimental wheat developed by Monsanto Co. The furor erupted just days after a May 25 protest in cities around the world targeting Monsanto, the leading developer of crops with transgenic DNA. At the crux of the concerns is the question of ...</p><br clear="all"/>

Source: http://rss.news.yahoo.com/rss/biotech

mexico news the talented mr ripley weather new orleans orcl the hartford illinois primary 2012 michael bay

Monday, July 29, 2013

What St Louis Cardinal player also played pro football?


Brian O'Neal Jordan while in the NFL played for the Atlanta Falcons. He also played in the MLB for the St. Louis Cardinals. He is retired. A:

Answered -

Source: http://www.chacha.com/question/what-st-louis-cardinal-player-also-played-pro-football

mike wallace mike wallace Paul Bearer Valerie Harper White Smoke Kwame Kilpatrick New pope 2013

Citi and The Wall Street Journal present a NY screening of Sony Pictures Animation's THE SMURFS 2 After Party

Fatima Ptacek (Dora the Explorer)

Fatima Ptacek (Dora the Explorer)

Lilla Crawford (Annie on Broadway)

Fatima Ptacek (Dora the Explorer)

Lalli Crawford (Annie on Broadway)

Lalli Crawford (Annie on Broadway)

Lilla Crawford (Annie on Broadway), Smurfs

Lilla Crawford (Annie on Broadway), Smurfs

Lilla Crawford (Annie on Broadway), Smurfs

Lilla Crawford (Annie on Broadway), Smurfs

Lilla Crawford (Annie on Broadway)

Roger Akiki, Roger Akiki, Justin Lewis, Juliana Akiki

Roger Akiki, Roger Akiki, Justin Lewis, Juliana Akiki

Source: http://www.patrickmcmullan.com/site/event_detail.aspx?eid=44653

jose canseco zimmerman derek fisher lyrid meteor shower hippocrates andrew breitbart penguins

Friday, April 26, 2013

Entire galaxies feel the heat from newborn stars: Bursts of star birth can curtail future galaxy growth

Apr. 25, 2013 ? When galaxies form new stars, they sometimes do so in frantic episodes of activity known as starbursts. These events were commonplace in the early Universe, but are rarer in nearby galaxies.

During these bursts, hundreds of millions of stars are born, and their combined effect can drive a powerful wind that travels out of the galaxy. These winds were known to affect their host galaxy -- but this new research now shows that they have a significantly greater effect than previously thought.

An international team of astronomers observed 20 nearby galaxies, some of which were known to be undergoing a starburst. They found that the winds accompanying these star formation processes were capable of ionising [1] gas up to 650 000 light-years from the galactic centre -- around twenty times further out than the visible size of the galaxy. This is the first direct observational evidence of local starbursts impacting the bulk of the gas around their host galaxy, and has important consequences for how that galaxy continues to evolve and form stars.

"The extended material around galaxies is hard to study, as it's so faint," says team member Vivienne Wild of the University of St. Andrews. "But it's important -- these envelopes of cool gas hold vital clues about how galaxies grow, process mass and energy, and finally die. We're exploring a new frontier in galaxy evolution!"

The team used the Cosmic Origins Spectrograph (COS) instrument [2] on the NASA/ESA Hubble Space Telescope to analyse light from a mixed sample of starburst and control galaxies. They were able to probe these faint envelopes by exploiting even more distant objects -- quasars, the intensely luminous centres of distant galaxies powered by huge black holes. By analysing the light from these quasars after it passed through the foreground galaxies, the team could probe the galaxies themselves.

"Hubble is the only observatory that can carry out the observations necessary for a study like this," says lead author Sanchayeeta Borthakur, of Johns Hopkins University. "We needed a space-based telescope to probe the hot gas, and the only instrument capable of measuring the extended envelopes of galaxies is COS."

The starburst galaxies within the sample were seen to have large amounts of highly ionised gas in their halos -- but the galaxies that were not undergoing a starburst did not. The team found that this ionisation was caused by the energetic winds created alongside newly forming stars.

This has consequences for the future of the galaxies hosting the starbursts. Galaxies grow by accreting gas from the space surrounding them, and converting this gas into stars. As these winds ionise the future fuel reservoir of gas in the galaxy's envelope, the availability of cool gas falls -- regulating any future star formation.

"Starbursts are important phenomena -- they not only dictate the future evolution of a single galaxy, but also influence the cycle of matter and energy in the Universe as a whole," says team member Timothy Heckman, of Johns Hopkins University. "The envelopes of galaxies are the interface between galaxies and the rest of the Universe -- and we're just beginning to fully explore the processes at work within them."

The team's results will appear in the 1 May 2013 issue of The Astrophysical Journal.

Notes

[1] A gas is said to be ionised when its atoms have lost one or more electrons -- in this case by energetic winds exciting galactic gas and knocking electrons out of the atoms within.

[2] Spectrographs are instruments that break light into its constituent colours and measure the intensity of each colour, revealing information about the object emitting the light -- such as its chemical composition, temperature, density, or velocity.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by ESA/Hubble Information Centre.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Journal Reference:

  1. Sanchayeeta Borthakur, Timothy Heckman, David Strickland, Vivienne Wild, David Schiminovich. THE IMPACT OF STARBURSTS ON THE CIRCUMGALACTIC MEDIUM. The Astrophysical Journal, 2013; 768 (1): 18 DOI: 10.1088/0004-637X/768/1/18

Note: If no author is given, the source is cited instead.

Disclaimer: Views expressed in this article do not necessarily reflect those of ScienceDaily or its staff.

Source: http://feeds.sciencedaily.com/~r/sciencedaily/top_news/top_science/~3/3ypRbNu_Qzk/130425103312.htm

Eddie Murphy Dead Democratic National Convention 2012 myocardial infarction What Is Labor Day jersey shore Pasquale Rotella Michael Clark Duncan